Abacus FCF Advisors’s Eli Lilly LLY Stock Holding History

Abacus FCF Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.9M	Buy	+13,274	New	+$13.6M	2.93%	5
2023 Q4	–	Sell	-4,057	Closed	-$2.18M	–	171
2023 Q3	$2.18M	Sell	4,057 -111	-3%	-$57.2K	1.16%	15
2023 Q2	$1.95M	Sell	4,168 -1,414	-25%	-$593K	0.99%	27
2023 Q1	$1.92M	Sell	5,582 -518	-8%	-$175K	1.03%	25
2022 Q4	$2.23M	Sell	6,100 -135	-2%	-$47.9K	1.46%	8
2022 Q3	$2.02M	Sell	6,235 -450	-7%	-$143K	1.39%	8
2022 Q2	$2.17M	Sell	6,685 -4,825	-42%	-$1.45M	1.33%	12
2022 Q1	$3.3M	Buy	+11,510	New	+$2.96M	1.1%	15
2019 Q3	–	Sell	-9,377	Closed	-$1.04M	–	103
2019 Q2	$1.04M	Sell	9,377 -1,065	-10%	-$125K	0.85%	86
2019 Q1	$1.35M	Buy	10,442 +435	+4%	+$52.9K	1.05%	44
2018 Q4	$1.16M	Buy	+10,007	New	+$1.12M	1.06%	38

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Abacus FCF Advisors's LLY Position: Q2 2026 in Review

Abacus FCF Advisors opened a new position in Eli Lilly (LLY) in Q2 2026: 13,274 shares worth $15.9M. The stake represents 2.93% of the portfolio and ranks #5 among its holdings. This is a return to the name: Abacus FCF Advisors previously reported a position in LLY as recently as Q3 2023.

Abacus FCF Advisors first reported a position in LLY in Q4 2018 and has held it in 11 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Abacus FCF Advisors held 13,274 shares of Eli Lilly worth $15.9M as of Q2 2026.
Eli Lilly was a new Abacus FCF Advisors position in Q2 2026.
Eli Lilly made up 2.93% of Abacus FCF Advisors's portfolio in Q2 2026, its #5 holding.
Abacus FCF Advisors first reported a position in Eli Lilly in Q4 2018 and has held it in 11 quarters since.
4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Abacus FCF Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.